Silver Book Fact

“Coronary heart disease spending has increased more than 40% over the past 15 years, and, as a whole, the health improvements have been well worth the costs. Over the entire population, spending on coronary heart disease and its major risk factors has resulted in a life-expectancy increase of 0.62 years, at an incremental cost of $43,600 per year of life gained. Life expectancy following a myocardial infraction has increased by nearly a year, at an incremental cost of $24,800 per life-year gained.”

Rosen A, Cutler D, Norton D, Hu H. The Value of Coronary Heart Disease Care for the Elderly: 1987-2002. Health Affairs. 2007; 26(1): 111-123. https://www.healthaffairs.org/doi/full/10.1377/hlthaff.26.1.111

Reference

Title
The Value of Coronary Heart Disease Care for the Elderly: 1987-2002
Publication
Health Affairs
Publisher
Project HOPE
Publication Date
2007
Authors
Rosen A, Cutler D, Norton D, Hu H
Volume & Issue
Volume 26, Issue 1
Pages
111-123
URL
Read Full Resource

Categories

  • Innovative Medical Research
  • Economic Value

Related Facts

  • About 2/3 of reduced mortality from cardiovascular disease is a result of medical interventions.  
  • It is estimated that the number of quality-adjusted life-years achieved with each $1 million spent on antihypertensive drug therapy is between 20-50 to more than 200.  
  • Patients Taking Medicines for Heart Failure Incur Lower Health Care Costs: Beta-blockers reduce total treatment costs for heart failure by $3,959  
  • Echocardiography and nuclear imaging are used for provocative “stress” testing of the heart. When combined with other forms of stress, both can identify the presence of coronary artery-obstructing lesions that…  
  • The rate of hospitalization from heart failure before and after transcatheter mitral valve repair (TMVR) decreases 73% (per patient year) in patients at prohibitive surgical risk.